Wednesday, August 19, 2026
RSS

Marcus Rivera

The Street Storyteller

Pharmaceutical

Curaleaf's Hostile Takeover Bid: A Game Changer for the Cannabis Industry

Curaleaf's $4/share bid for Aurora Cannabis could reshape the cannabis landscape, creating ripples a…

Aug 18, 2026
Markets & Money

30-Year Treasury Yield at 19-Year High: What It Means for US and Canadian Markets

The 30-year US Treasury yield has hit a 19-year high, reshaping market landscapes and investor strat…

Aug 18, 2026
Tech

Nvidia's Strategic Move: Financing OpenAI's Data Center in Ohio

Nvidia's financing of OpenAI's data center marks a pivotal moment in AI infrastructure and investor …

Aug 17, 2026
Markets & Money

S&P 500's Record Surge: What Lies Beneath the Earnings Rally?

The S&P 500 hits record highs, but analysts raise questions about the sustainability of this earning…

Aug 17, 2026
Pharmaceutical

Iovance Biotherapeutics' Q2 Earnings: Strong Momentum in Oncology

Iovance Biotherapeutics showcases promising developments in oncology, highlighted by a key FDA desig…

Aug 16, 2026
Markets & Money

Phillips 66 and Marathon Petroleum in Merger Talks: What a Refining Megadeal Could Mean for Traders

Phillips 66 and Marathon Petroleum held takeover discussions, signaling potential industry consolida…

Aug 15, 2026
Pharmaceutical

BridgeBio Pharma Stock Gains 29%: Analyzing Wall Street's Confidence

BridgeBio Pharma's stock has surged 29% in three months, reflecting strong earnings and bullish anal…

Aug 14, 2026
Markets & Money

Analyzing Treasury Yield Movements Amid Geopolitical Tensions

As Treasury yields rise, geopolitical tensions and manufacturing data shape market landscapes.

Aug 14, 2026
Critical Minerals

Mobix Labs Ventures into Critical Minerals: Strategic Acquisition Explained

Mobix Labs' strategic acquisition marks a pivotal shift into critical minerals, reshaping its market…

Aug 13, 2026
Markets & Money

Clean Harbors Expands Footprint with $470 Million EnviroServe Acquisition

Clean Harbors is set to bolster its environmental services capabilities with the $470 million acquis…

Aug 12, 2026
Markets & Money

Nasdaq's Strategic Acquisition of LeveL Markets: Implications for 24/7 Trading

Nasdaq's acquisition of LeveL Markets signals a major shift towards extended trading hours, reshapin…

Aug 11, 2026
Markets & Money

H&R REIT's C$6.7 Billion Take-Private: A Game Changer for Canadian Real Estate?

H&R REIT's C$6.7 billion acquisition could reshape the Canadian commercial real estate landscape.

Aug 11, 2026
Pharmaceutical

Amneal Pharmaceuticals Strengthens Market Position with Kashiv BioSciences Acquisition

Amneal's acquisition of Kashiv BioSciences positions it as a leader in the biosimilars market, enhan…

Aug 10, 2026
Tech

Teledyne's $1.1B Deal for Varex Imaging: Analyzing Market Implications

Teledyne's acquisition of Varex Imaging boosts shares and reshapes the medical imaging landscape.

Aug 10, 2026
Markets & Money

S&P 500 Hits New Highs: Analyzing Market Dynamics and Implications for Investors

The S&P 500 reaches record highs, driven by options activity and a low VIX, reshaping investment str…

Aug 9, 2026
Pharmaceutical

iRhythm's Strong Q2 Earnings and Vital Connect Acquisition: A Sign of Growth

iRhythm's Q2 earnings beat and acquisition of Vital Connect signal promising growth in wearable heal…

Aug 8, 2026
Markets & Money

Celsius Holdings Soars on Rockstar Energy Founder’s Stake Acquisition

Russ Savage's acquisition of a stake in Celsius Holdings sparks speculation and market movement.

Aug 7, 2026
Critical Minerals

Critical Minerals in Focus: Trump's Meeting with Mining CEOs and Its Market Implications

The Trump administration's focus on critical minerals highlights opportunities for investors in Lomi…

Aug 7, 2026
Pharmaceutical

Harrow's Strategic Acquisition of TYRVAYA: A Game-Changer for Ophthalmic Treatments

Harrow's acquisition of TYRVAYA positions it as a key player in ophthalmic treatments, offering pote…

Aug 6, 2026
Pharmaceutical

Harrow's Acquisition of TYRVAYA: A Game Changer for Dry Eye Treatment

Harrow Pharmaceuticals acquires TYRVAYA, the first FDA-approved nasal spray for dry eye disease, res…

Aug 6, 2026